Digital Library
Close Browse articles from a journal
 
   next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 1 of 47 found articles
 
 
  Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial
 
 
Title: Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial
Author: Velikova, Galina
Morden, James P
Haviland, Joanne S
Emery, Charlotte
Barrett-Lee, Peter
Earl, Helena
Bloomfield, David
Brunt, Adrian Murray
Canney, Peter
Coleman, Robert
Verrill, Mark
Wardley, Andrew
Bertelli, Gianfilippo
Ellis, Paul
Stein, Rob
Bliss, Judith M
Cameron, David
Appeared in: Lancet oncology
Paging: Volume 24 () nr. 12 pages 1359-1374
Year: 2023
Contents:
Publisher: The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 1 of 47 found articles
 
   next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands